Teva seeks to reinvent itself as branded drug developer
After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Teva's drug development pipeline.
Source: globes.co.il
Global Rd Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Rd Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Rd Division Today - Breaking & Trending Today
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
/PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) today announced an agreement to jointly develop and commercialize KHK4083, which is...
Source: prnewswire.com
Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis
Press release content from Business Wire. The AP news staff was not involved in its creation. Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis February 18, 2021 GMT TOKYO--(BUSINESS WIRE)--Feb 18, 2021-- For Medical Media only. Kyowa Kirin Co., Ltd. (TSE: 4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”), a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, announces today that the Phase 2 study of investigational agent KHK4083 in...
Source: apnews.com